Risk Factors for Influenza-Induced Exacerbations and Mortality in Non-Cystic Fibrosis Bronchiectasis

Author:

Huang Hung-Yu123ORCID,Lo Chun-Yu12,Chung Fu-Tsai123,Huang Yu-Tung4ORCID,Ko Po-Chuan4ORCID,Lin Chang-Wei12,Huang Yu-Chen12,Chung Kian Fan56ORCID,Wang Chun-Hua12ORCID

Affiliation:

1. Department of Thoracic Medicine, Chang Gung Memorial Hospital, Taipei 105, Taiwan

2. College of Medicine, Chang Gung University, Taoyuan 333, Taiwan

3. Department of Thoracic Medicine, New Taipei City Municipal TuCheng Hospital, Chang Gung Medical Foundation, New Taipei City 236, Taiwan

4. Center for Big Data Analytics and Statistics, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan

5. Airway Disease Section, National Heart and Lung Institute, Imperial College London, London W2 1PG, UK

6. Biomedical Research Unit, Royal Brompton Hospital, London SW7 2BX, UK

Abstract

Influenza infection is a cause of exacerbations in patients with chronic pulmonary diseases. The aim of this study was to investigate the clinical outcomes and identify risk factors associated with hospitalization and mortality following influenza infection in adult patients with bronchiectasis. Using the Chang Gung Research Database, we identified patients with bronchiectasis and influenza-related infection (ICD-9-CM 487 and anti-viral medicine) between 2008 and 2017. The main outcomes were influenza-related hospitalization and in-hospital mortality rate. Eight hundred sixty-five patients with bronchiectasis and influenza infection were identified. Five hundred thirty-six (62%) patients with bronchiectasis were hospitalized for influenza-related infection and 118 (22%) patients had respiratory failure. Compared to the group only seen in clinic, the hospitalization group was older, with more male patients, a lower FEV1, higher bronchiectasis aetiology comorbidity index (BACI), and more acute exacerbations in the previous year. Co-infections were evident in 55.6% of hospitalized patients, mainly caused by Pseudomonas aeruginosa (15%), fungus (7%), and Klebsiella pneumoniae (6%). The respiratory failure group developed acute kidney injury (36% vs. 16%; p < 0.001), and shock (47% vs. 6%; p < 0.001) more often than influenza patients without respiratory failure. The overall mortality rate was 10.8% and the respiratory failure group exhibited significantly higher in-hospital mortality rates (27.1% vs. 6.2%; p < 0.001). Age, BACI, and previous exacerbations were independently associated with influenza-related hospitalization. Age, presence of shock, and low platelet counts were associated with increased hospital mortality. Influenza virus caused severe exacerbation in bronchiectasis, especially in those who were older and who had high BACI scores and previous exacerbations. A high risk of respiratory failure and mortality were observed in influenza-related hospitalization in bronchiectasis. We highlight the importance of preventing or treating influenza infection in bronchiectasis.

Funder

Chang Gung Memorial Hospital

Publisher

MDPI AG

Subject

Virology,Infectious Diseases

Reference50 articles.

1. Inflammation: A two-edged sword--the model of bronchiectasis;Cole;Eur. J. Respir. Dis. Suppl.,1986

2. Pulmonary exacerbation in adults with bronchiectasis: A consensus definition for clinical research;Hill;Eur. Respir. J.,2017

3. Characterization of the “frequent exacerbator phenotype” in bronchiectasis;Chalmers;Am. J. Respir. Crit. Care Med.,2018

4. The bronchiectasis severity index. An international derivation and validation study;Chalmers;Am. J. Respir. Crit. Care Med.,2014

5. The microbiome in bronchiectasis;Richardson;Eur. Respir. Rev.,2019

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3